# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
AstraZeneca's Truqap (capivasertib) in combination with Faslodex (fulvestrant) has been approved in Japan for the treatment...
https://www.soundhound.com/newsroom/press-releases/first-for-japan-as-soundhound-ais-voice-assistant-with-integrated-chatgpt-la...